DB14781Investigational
Vofatamab is under investigation in clinical trial NCT02401542 (Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma).
- Mechanism
- Curator reviewed
Pharmacologically active on Fibroblast growth factor receptor 3
- Also known as
- MFGR1877S
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Vofatamab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account